Heartburn Drug Cancer Lawsuit

New Scientific Research Links Acid Reflux Drugs to Cancer

Attention: The Schmidt National Law Group is no longer accepting these cases.

Proton Pump Inhibitor (PPI) medications and histamine-2 (H2) blockers are regularly used by tens of millions of Americans to control gastroesophageal reflux disease (GERD), acid reflux and heartburn. H2 blockers (Zantac and ranitidine) are often prescribed to patients recovering from ulcers. Both over-the-counter and prescription versions of PPI’s and H2 blockers are marketed to consumers as safe and effective for long-term usage with minimal side effects until adverse effects reported to the FDA began to spike with patients reporting kidney failure, esophageal cancer and stomach cancer.

January 27, 2022 – Zantac MDL Lawsuit Update.

As the Zantac litigation continues an update from the parties in the multidistrict litigation (MDL) has a plan to narrow the field of more than 130,000 personal injury claimants and will serve as plaintiffs in the first bellwether trials scheduled for 2023.

Earlier in October of last year, the court stated that the makers of the brand-name heartburn drugs couldn’t escape claims from a medical monitoring class, which could potentially cover hundreds of thousands of Zantac users that haven’t been diagnosed with cancer but are seeing damages from the costs of medical screenings and various treatments should they be diagnosed in the future.

Even more recently, major drug stores and pharmacies recalled the H2 blocker Zantac (ranitidine) after an FDA warning that the medications may have a huge impact on specific gastric and intestinal cancers.

Now a results of a new study involving the effects of long-term usage of PPIs has concluded that these medications may be even more dangerous by significantly increasing a patient’s risk of developing gastric, stomach & esophageal cancers.

The study, which was recently published in Gut medical journal, an academic publication that focuses on stomach health research, examined people who were regular users of either over-the-counter or prescription PPI drugs for 3 or more years. Although stomach cancer is quite rare, of the patients studied on proton pump inhibitors it appears that the drug may have doubled their risk of being diagnosed with the deadly disease. What is even more alarming is that those taking the medications for three years or longer showed an 8 times higher likelihood of developing stomach cancer.

We must be skeptical in health studies like this, however, and look at other factors that may come in to play that appear as a correlation but does not equate to causality. Many other health issues such as smoking, drinking and obesity, for example, can contribute to these cancers and this particular study fails to factor these in to the numbers. On the other hand, this is not the first time a scientific research study has linked the popular heartburn medications to cancer. In 2011 a research team of scientists at the University of Pittsburgh discovered a link between PPI’s and an increased risk of developing esophageal cancer. Another study later found the medications doubled a patient’s odds of developing stomach cancer.

Proton pump inhibitors like AstraZeneca’s Nexium work by limiting the stomach’s ability to create acid and therefore reduces the occurrence of heartburn and acid reflux. The effectiveness of Nexium is obvious by looking at the drug’s popularity. In 2016 alone, Nexium sales exceeded $2 billion.

In another study, scientists examined the medical records of 700,000 people who have been regularly using Nexium, Prilosec and Prevacid and compared them with the general population. The results were very similar to the previous studies: those taking PPI’s were significantly more likely to develop these kinds of cancers.

It is still in the very early stages of PPI health risk research and it should be stated that those concerned about their own usage of the popular heartburn medications should speak with their doctor about the likelihood of developing gastric cancer, esophageal cancer and stomach cancer.

What are the side effects of proton pump inhibitors (PPIs)?

The most common side effects of proton pump inhibitors are:

• Headache
• Diarrhea
• Constipation
• Abdominal pain
• Flatulence
• Fever
• Vomiting
• Nausea
• Rash

More serious side effects associated with PPI use include:

1. Serious allergic reactions
2. Stevens-Johnson syndrome
3. Toxic epidermal necrolysis
4. Reduced kidney function
5. Pancreatitis
6. Reduced liver function
7. Erythema multiforme

High doses of PPI medications and long-term usage of 1yr or longer may increase the risk of osteoporosis-related fractures.

What are the most common acid reflux medications categorized as PPI’s?

Available proton pump inhibitors include:

• omeprazole (Prilosec, Prilosec OTC)
• omeprazole/sodium bicarbonate (Zegerid, Zegerid OTC)
• esomeprazole (Nexium, Nexium IV, Nexium 24 HR)
• lansoprazole (Prevacid, Prevacid IV, Prevacid 24-Hour)
• aspirin and omeprazole (Yosprala)
• dexlansoprazole (Dexilent, Dexilent Solutab)
• rabeprazole (Aciphex, Aciphex Sprinkle)
• pantoprazole (Protonix)
• esomeprazole magnesium/naproxen (Vimovo)

What to do if you have been diagnosed with gastric cancer, esophageal cancer or stomach cancer after long-term PPI use?

First and foremost, stick to your doctor’s recommendations regarding treatment and whether or not to continue taking PPI medications. Next, get professional legal help by contacting Schmidt National Law Group today for a free case evaluation by calling 1-800-631-5656.